greeksoup/ stock research
Stock research / United States / NVS / Year to 31 December 2024

Novartis AG (NVS) annual results, year to 31 December 2024: revenue USD 50,317 million, from the 20-F

Novartis AG files a 20-F with the SEC once a year, in US dollars. In the year to 31 December 2024 it reported revenue from the sale of goods of USD 50,317 million, up 10.7% on the year before. Its profit attributable to shareholders was USD 11,941 million, down 19.6%, and diluted earnings per share USD 5.87.

Revenue
USD 50,317 million
+10.7% on the year
FY2017FY2024
Operating margin
28.9%
21.5% a year earlier
FY2017FY2024
Net income
USD 11,941 million
-19.6% on the year
FY2017FY2024
Diluted EPS
USD 5.87
-17.3% on the year
FY2017FY2024

this yearthe year beforeIn US dollars as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2023Dec 2024
Revenue from the sale of goods45,44050,317
Cost of sales12,47212,827
Gross profit34,18838,895
Research and development11,37110,022
Selling, general and administrative12,51712,566
Operating profit9,76914,544
Profit before tax9,12313,640
Income tax5511,701
Profit for the year14,85411,939
Profit attributable to shareholders14,85011,941
Filing20-F20-F
USD million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2023Dec 2024
Diluted EPS7.105.87
Basic EPS7.155.92
Filing20-F20-F

USD per ordinary share, as filed.

Cash flow

Year toDec 2023Dec 2024
Cash from operations14,45817,619
Purchase of property, plant and equipment1,0601,366
Free cash flow13,39816,253
Cash from investing5,596-7,513
Cash from financing-14,278-11,742
Buybacks8,7198,331
Dividends paid7,2557,624
Filing20-F20-F

USD million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2023Dec 2024
Funded by
Equity attributable to shareholders46,66744,046
Non-controlling interests83.080.0
Borrowings, as filed20,62724,722
Lease liabilities1,8281,803
Other liabilities30,74031,595
Total equity and liabilities99,945102,246
Owned
Property, plant and equipment9,5149,458
Goodwill23,34124,756
Other intangible assets26,87926,915
Cash and cash equivalents13,39311,459
Inventories5,9135,723
Other assets20,90523,935
Total assets99,945102,246
Filing20-F20-F

USD million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2023Dec 2024
Return on year-end equity31.8%27.1%
Effective tax rate6.0%12.5%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2024, filed 4 February 2026: the filing. The figures are in US dollars as filed.